Our Mission

Learn who we are and how we serve our community

Leadership

Meet our leaders, trustees and team

Foundation

Developing the next generation of talent

C+CT

Covering the latest news and trends in the marketplaces industry

Industry Insights

Check out wide-ranging resources that educate and inspire

Government Relations & Public Policy

Learn about the governmental initiatives we support

Events

Connect with other professionals at a local, regional or national event

Virtual Series

Find webinars from industry experts on the latest topics and trends

Professional Development

Grow your skills online, in a class or at an event with expert guidance

Find Members

Access our Member Directory and connect with colleagues

ICSC Networking Platform

Get recommended matches for new business partners

Student Resources

Find tools to support your education and professional development

Become a Member

Learn about how to join ICSC and the benefits of membership

Renew Membership

Stay connected with ICSC and continue to receive membership benefits

Industry News

A CVS-Aetna deal could prove a bitter pill for Amazon

October 30, 2017

Reports that CVS is in talks to buy health insurer Aetna — unconfirmed so far — indicate that the pharmacy chain has Amazon.com on its mind. Amazon clearly wants to sell prescription drugs: The online giant has obtained approval for wholesale pharmacy licenses in at least 12 states.

As CNBC points out, owning Aetna would put CVS in a stronger position to negotiate cheaper drug prices and could also lead to cheaper copayments for the insured. Then, too, that vast network of stores could be harnessed to provide a cost-effective distribution center and an in-store clinic network.

CVS has been reinventing itself as a health-care business for years through its in-store clinics, so this deal would accelerate a transformation that is already in motion anyway. Furthermore, CVS and Aetna already forged an agreement to work together in 2010. So by buying Aetna, CVS could be making Amazon’s march into the prescription drug business anything but a cakewalk.

By Edmund Mander

Director, Editor-In-Chief/SCT

Commerce + Communities Today

Members get exclusive access to this magazine with news and trends for the rapidly evolving marketplaces industry.

Sign up now